Open AccessMorphine May Contribute to Improving Respiratory Failure in Severe COVID-19: A Case Report
Author(s) -
Yukako Tanaka-Yagi,
Takashi Yamaguchi,
Yoshinobu Matsuda,
Masanori Mori,
Tomofumi Ikari,
Satoru Miwa,
Kozue Suzuki,
Ryo Tachikawa,
Kyosuke Nakata,
Masayuki Kanatani
Publication year - 2022
Publication title -
indian journal of palliative care/indian journal of palliative care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 26
eISSN - 1998-3735
pISSN - 0973-1075
DOI - 10.25259/ijpc_132_2021
Subject(s) - medicine , covid-19 , pandemic , dexamethasone , morphine , respiratory failure , respiratory system , disease , anesthesia , intensive care medicine , infectious disease (medical specialty) , virology , outbreak
At present, the world is undergoing successive waves of the COVID-19 pandemic. When COVID-19 becomes severe, it causes respiratory failure and symptoms of dyspnoea. The patient's dyspnoea worsens to the IPOS of 3. One COVID-19 patient admitted to our medical institution developed severe illness characterised by hypoxaemia and dyspnoea. In addition to disease-modifying treatments such as remdesivir and dexamethasone, we administered morphine to relieve his dyspnoea. Surprisingly, we observed an improvement in both hypoxaemia and dyspnoea.